FDA reissues post on recall of lead-contaminated CBD oil from Florida manufacturer

The U.S. Food and Drug Administration has updated a post on its website to spread the word about a Florida company that recalled a batch of CBD oil after a state agency tested the product and found that it contained dangerous levels of lead.

Summitt Labs is voluntarily recalling Lot #730 Batch #K018 of its Kore Organic Watermelon CBD Oil Tincture, sold in a 30 milliliter bottle. According to the FDA, the Florida Department of Agriculture and Consumer Services tested a random sample and found the product to contain lead levels at 4.7 parts per million.

The FDA noted that it had updated the post this week to correct the lot number and batch number of the contaminated product, but reports from May appear to indicate that the correct lot and batch were cited in the original FDA posting.

The Tampa-based CBD maker had already issued an immediate voluntary recall for the product at the consumer level in May. It also began an internal investigation and notified the U.S. Food and Drug Administration, which posted the company announcement on its agency website.